These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20967861)
1. Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models. Ishiguro A; Akiyama T; Adachi H; Inoue J; Nakamura Y Arthritis Rheum; 2011 Feb; 63(2):455-66. PubMed ID: 20967861 [TBL] [Abstract][Full Text] [Related]
2. Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A/F. Adachi H; Ishiguro A; Hamada M; Sakota E; Asai K; Nakamura Y Biochimie; 2011 Jul; 93(7):1081-8. PubMed ID: 21524680 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis. Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264 [TBL] [Abstract][Full Text] [Related]
4. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis. Chao CC; Chen SJ; Adamopoulos IE; Davis N; Hong K; Vu A; Kwan S; Fayadat-Dilman L; Asio A; Bowman EP Autoimmunity; 2011 May; 44(3):243-52. PubMed ID: 20925596 [TBL] [Abstract][Full Text] [Related]
5. Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis. Uyttenhove C; Sommereyns C; Théate I; Michiels T; Van Snick J Ann N Y Acad Sci; 2007 Sep; 1110():330-6. PubMed ID: 17911448 [TBL] [Abstract][Full Text] [Related]
6. Functional specialization of interleukin-17 family members. Iwakura Y; Ishigame H; Saijo S; Nakae S Immunity; 2011 Feb; 34(2):149-62. PubMed ID: 21349428 [TBL] [Abstract][Full Text] [Related]
7. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788 [TBL] [Abstract][Full Text] [Related]
8. IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. Lo Re S; Dumoutier L; Couillin I; Van Vyve C; Yakoub Y; Uwambayinema F; Marien B; van den Brûle S; Van Snick J; Uyttenhove C; Ryffel B; Renauld JC; Lison D; Huaux F J Immunol; 2010 Jun; 184(11):6367-77. PubMed ID: 20421647 [TBL] [Abstract][Full Text] [Related]
9. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. Hu Y; Ota N; Peng I; Refino CJ; Danilenko DM; Caplazi P; Ouyang W J Immunol; 2010 Apr; 184(8):4307-16. PubMed ID: 20231694 [TBL] [Abstract][Full Text] [Related]
10. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Iwakura Y; Nakae S; Saijo S; Ishigame H Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416 [TBL] [Abstract][Full Text] [Related]
11. Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity. Mangan PR; Su LJ; Jenny V; Tatum AL; Picarillo C; Skala S; Ditto N; Lin Z; Yang X; Cotter PZ; Shuster DJ; Song Y; Borowski V; Thomas RL; Heimrich EM; Devaux B; Das Gupta R; Carvajal I; McIntyre KW; Xie J; Zhao Q; Struthers M; Salter-Cid LM J Pharmacol Exp Ther; 2015 Aug; 354(2):152-65. PubMed ID: 26015463 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481 [TBL] [Abstract][Full Text] [Related]
13. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Fitzgerald DC; Zhang GX; El-Behi M; Fonseca-Kelly Z; Li H; Yu S; Saris CJ; Gran B; Ciric B; Rostami A Nat Immunol; 2007 Dec; 8(12):1372-9. PubMed ID: 17994023 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Baldeviano GC; Barin JG; Talor MV; Srinivasan S; Bedja D; Zheng D; Gabrielson K; Iwakura Y; Rose NR; Cihakova D Circ Res; 2010 May; 106(10):1646-55. PubMed ID: 20378858 [TBL] [Abstract][Full Text] [Related]
15. The IL-17 pathway as a major therapeutic target in autoimmune diseases. Hu Y; Shen F; Crellin NK; Ouyang W Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836 [TBL] [Abstract][Full Text] [Related]
16. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Sonderegger I; Kisielow J; Meier R; King C; Kopf M Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146 [TBL] [Abstract][Full Text] [Related]
17. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Ishigame H; Kakuta S; Nagai T; Kadoki M; Nambu A; Komiyama Y; Fujikado N; Tanahashi Y; Akitsu A; Kotaki H; Sudo K; Nakae S; Sasakawa C; Iwakura Y Immunity; 2009 Jan; 30(1):108-19. PubMed ID: 19144317 [TBL] [Abstract][Full Text] [Related]
18. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Uyttenhove C; Van Snick J Eur J Immunol; 2006 Nov; 36(11):2868-74. PubMed ID: 17048276 [TBL] [Abstract][Full Text] [Related]
19. The IL-17 cytokine family. Gaffen SL; Kramer JM; Yu JJ; Shen F Vitam Horm; 2006; 74():255-82. PubMed ID: 17027518 [TBL] [Abstract][Full Text] [Related]
20. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]